Harvard Bioscience, Inc. (HBIO)
8.09
-0.22
(-2.65%)
USD |
NASDAQ |
Oct 16, 16:00
8.09
0.00 (0.00%)
After-Hours: 20:00
Harvard Bioscience Research and Development Expense (Annual) : 8.825M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 8.825M |
| December 31, 2024 | 10.41M |
| December 31, 2023 | 11.76M |
| December 31, 2022 | 12.33M |
| December 31, 2021 | 10.80M |
| December 31, 2020 | 8.685M |
| December 31, 2019 | 10.72M |
| December 31, 2018 | 10.99M |
| December 31, 2017 | 5.645M |
| December 31, 2016 | 5.392M |
| December 31, 2015 | 6.42M |
| December 31, 2014 | 4.88M |
| December 31, 2013 | 4.154M |
| December 31, 2012 | 7.321M |
| December 31, 2011 | 5.434M |
| Date | Value |
|---|---|
| December 31, 2010 | 4.709M |
| December 31, 2009 | 4.396M |
| December 31, 2008 | 4.048M |
| December 31, 2007 | 3.708M |
| December 31, 2006 | 3.154M |
| December 31, 2005 | 2.95M |
| December 31, 2004 | 2.981M |
| December 31, 2003 | 6.263M |
| December 31, 2002 | 4.146M |
| December 31, 2001 | 3.178M |
| December 31, 2000 | 1.533M |
| December 31, 1999 | 1.188M |
| December 31, 1998 | 0.3248M |
| December 31, 1997 | 0.2065M |
| December 31, 1996 | 0.34M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Agilent Technologies, Inc. | 450.00M |
| Bio-Rad Laboratories, Inc. | 257.60M |
| Bruker Corp. | 395.20M |
| Danaher Corp. | 1.598B |
| Illumina, Inc. | 951.00M |